MicroRNA-1247 inhibits cell proliferation by directly targeting ZNF346 in childhood neuroblastoma
© The Author(s) 2018
Received: 9 November 2017
Accepted: 21 May 2018
Published: 24 May 2018
Neuroblastoma (NB) represents the most common extracranial solid tumor in children. Accumulating evidence shows that microRNAs (miRs) play an important role in the carcinogenesis of NB. Here, we investigated the biological function of miR-1247 in NB in vitro.
We found miR-1247 was downregulated in NB tissues and cells using quantitative PCR analysis. Gain- and loss-of-function studies demonstrated that miR-1247 significantly suppressed cell proliferation and induced cell cycle G0/G1 phase arrest and cell apoptosis of NB cells in vitro by using MTT, colony formation assay and Flow cytometry analysis. Luciferase assay suggested ZNF346 was the target of miR-1247 and its expression could be downregulated by miR-1247 overexpression using Western blotting. Furthermore, downregulation of ZNF346 by siRNA performed similar effects with overexpression of miR-1247 in NB cells.
Our findings suggested miR-1247 directly targeted to repress ZNF346 expression, thus suppressing the progression of NB, which might be a novel therapeutic target against NB.
Neuroblastoma (NB) is a malignancy of peripheral sympathetic nervous system that frequently occurs in children and is derived from the improper differentiation of primitive neural crest cells during embryonic development [1, 2]. These tumors usually arise in the adrenal medullar, posterior mediastinum, and abdominal sympathetic ganglia [3, 4]. Although NB constitutes only approximately 8% of pediatric malignancies, it is responsible for 15% of cancer-related deaths . In recent years, remarkable therapeutic management has been made for children with early stage NB. However, patients with advanced stages remain practically incurable despite dramatic escalations in the cytotoxic chemoradiotherapy. Hence, there is an urgent medical need for exploration of new treatment strategies.
MicroRNAs (miRs) are a class of small, ~ 22- nucleotide long non-coding RNAs, which completely or partially complementary with the 3′UTR of their target mRNA to directly repress post-transcription [6, 7]. In fact, a surprisingly large number of annotated miRs (with more than 1000) have been found in humans and considered to affect multiple physiological and developmental processes . Moreover, accumulating reports have described dysfunction and implication of miRs in various diseases, including cancer, cardiovascular and Alzheimer’s disease [9–13]. Recently, several tumorigenic suppression or promotion property procedures, miRNAs, such as miR-584-5p targeting matrix metalloproteinase 14 , miR-329 and miR-137 targeting KDM1A [15, 16], miR-542-3p downregulating Survivin expression , and miR-92a repressing TrkA expression , have been shown in NB.
One miRNA that has obtained special attention in the cancer research field is microRNA-1247 (miR-1247), the expression of which is altered in pancreatic cancer , prostate cancer , non-small-cell lung cancer (NSCLC)  and hepatocellular carcinoma . Shi et al.  showed that high expression of miR-1247 related to prognosis of pancreatic cancer and depressed scell growth through targeting neuropilins. DNA methylation induced knockdown of miR-1247 enhanced proliferation and metastasis of NSCLC cells . Furthermore, miR-1247 exerted antitumor effects on hepatocellular carcinoma by inhibition proliferative and invasive capabilities of tumor cells . Whereas, the role and mechanism of miR-1247 in NB has never been reported. ZNF346, which is widely expressed in brain, belongs to a new class of C2H2-type zinc finger proteins . It is also a SIRT-interacting protein that protects neurons in tissue culture models of neurodegenerative disease by suppressing cell-cycle re-entry though triggering expression of p21 . In the present study, we have investigated miR-1247 expression patterns in NB and adjacent tissues. Subsequently, we further investigated the roles of miR-1247 in the regulation of the malignant phenotypes of NB and its underlying mechanisms.
Materials and methods
Patient tissue samples
Fresh tumor specimens from 10 well-established primary NB cases and the corresponding adjacent normal nerve tissues were collected from the Department of Pediatrics, the First People’s Hospital of Jingzhou (Hubei, China) and snap frozen immediately at − 80 °C until use. The pathological diagnosis of NB was confirmed by at least two pathologists. These 10 patients include 4 female and 6 male. The mean age is 45 years. According to international neuroblastoma staging system, 4 patients were classified as stage 1, 4 as stage 2 and 3 as stage 3. Patient’s written consent and approval to conduct this study was obtained from the First People’s Hospital of Jingzhou.
Cell culture and transfection
Human NB cell lines (SH-SY5Y and SK-N-SH) were purchased from Shanghai Institute of Biochemistry and Cell Biology (Shanghai, China) and cultured in RPMI-1640 medium supplemented with 10% FBS, 100 IU/ml penicillin and 10 mg/mL streptomycin. All cells were maintained in an atmosphere of 5% CO2 at 37 °C.
For cell transfection, the miR-1247 mimics, miR-1247 inhibitor, small interfering RNA for ZNF346 (siZNF346) and their corresponding negative control oligonucleotides (NC-mimics, NC-inhibitor and si-NC, respectively) were chemically synthesized by GenePharma Co. Ltd. (Shanghai, China). The 100 nmol of above oligonucleotides were transfected into confluent cells with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacture’s instruction. After 48 h of transfection, cells were used for the following in vitro experiments.
Quantification of miR-1247 expression
Total miRNA was extracted from primary tissues and cell lines using miRNeasy Mini Kit (Qiagen). Then cDNA was synthesized with a miRNA-specific stem-loop primer and the TaqMan MiRNA Reverse Transcription Kit (Applied Biosystems). Subsequently, the quantitative PCR was performed on a CFX96 Touch Real-Time PCR Detection System (BioRad) using the follow primers: miR-1247 forward: AACGCTCAGCACCCATTTAC and miR-1247 reverse: CGGACGTTGCTCTCTACCC; U6 forward: CTCGCTTCGGCAGCACA and U6 reverse: AACGCTTCACGAATTTGCGT. PCR parameters were as follows: 95 °C for 3 min, 40 cycles of 95 °C for 10 s, and 58 °C for 30 s. Relative miR-1247 expression was calculated using the 2−ΔΔCt method with normalization to U6 snRNA.
Transfected cells were seeded at a density of 1 × 106 cells per dish in 6-cm dishes. After 96 h of culture, cellular protein was extracted with RIPA buffer (20 mM Tris–HCl pH 7.5, 10 mM EDTA, 150 mM NaCl, and 1% Sodium dexoycholate, 0.1% SDS). Protein concentration was determined using a BCA protein assay kit (Thermo). Following denaturation in boiling water for 5 min, approximately 30 µg of protein extracts were separated on 10% SDS-PAGE gels and transfected onto polyvinylidene fluoride (PVDF) membranes (Millipore, MA, USA). After blocked with non-fat milk, the membranes were incubated with primary antibodies against ZNF346 (1:1000, #35964, Cell Signaling Technology), CDK1 (1:1000, 11026-1-AP, Proteintech), Cyclin D1 (1:1000, 60186-1-1 g, Proteintech), caspase-3 (1:1000, 25546-1-AP, Proteintech), Bcl-2 (1:1000, #2876, Proteintech) and GAPDH (1:5000, 10494-1-AP, Proteinintech) overnight at 4 °C and then incubated in the corresponding secondary antibody for 2 h at room temperature. Bands were detected with Enhanced chemiluminescence substrate kit (Amersham, Piscataway, NJ). GAPDH was used as an internal control.
Cells were planted in 96-well plates at a density of 3,000 cells per well. A total of 100 µl of MTT solution (0.5 mg/ml, Sigma-Aldrich, St. Louis, MO, USA) was added into each well and the cells were incubated for 4 h at 37 °C. At 1, 2, 3, 4, and 5 day after culture, the optical density (OD) value in each well was recorded using a microplate reader at 595 nm wavelength.
Cells with miR-1247 overexpression or knockdown were seeded into 6-well plates at a density of 500 cells per well. After cultured for 5 days, the cells were washed with PBS and fixed with 10% formaldehyde for 5 min followed by staining with 0.5% crystal violet for 3 min. The colonies (more than 50 cells per colony) was photographed and manually counted with an inverted microscope.
Flow cytometry analysis
Cell cycle distribution was detected using propidium iodide (PI) staining. Briefly, transfected cells were seeded at a density of 1 × 106 cells per dish in 6-cm dishes. After 48 h of incubation, cells were collected and fixed in pre-cooling 70% ethanol at 4 °C overnight. The following day, immobilized cells were collected, wished and resuspended in 500 μl PBS containing 50 μg/ml PI, 100 μg/ml RNase A and 0.2% Triton X-100. After incubated in dark at room temperature for 30 min, the cells were analyzed using a BD FACSCalibur Flow Cytometer (BD Biosciences, CA, USA).
Cells apoptosis was analyzed using AnnexinV-FITC/PI Kit (BD Pharminogen, USA) according to the manufacturer’s instructions. Briefly, transfected cells were seeded in 6-cm dishes at a density of 1 × 106 cells per dish. After 48 h of culture, the cells were collected and stained with Annexin V-FITC (5 μl) and PI (10 μl) in the dark. After washing twice with PBS, the cells were collected and analyzed using a BD FACSCalibur Flow Cytometer (BD Biosciences, CA, USA). Each treatment was performed for three times.
Dual-luciferase activity assay
The interaction between 3′-UTR of ZNF346 and miR-1247 was detected using Luciferase activity assay. The psiCHECKTM vector used for LUC assays was purchased from Promega (Madison, Wisconsin, USA). The wild or mutant type 3′UTR sequences of ZNF346 containing the predicted miR-1247 binding sites were cloned into the psiCHECK-2 vector (Promega Corporation) to construct dual luciferase reporter vector. QuikChangeTM Site-Directed Mutagenesis kit (Agilent Technologies, Inc., Santa Clara, CA, USA) was used to mutagenize the miR-ZNF binding site according to the manufacturer’s protocol. For cell transfection, NB cells were seeded in 96-wells plates and incubated for 24 h. Then cells were harvested and co-transfected with 200 ng of psiCHECK-ZNF346 3′UTR wild type (WT) or psiCHECK-ZNF346 3′UTR mutant (MUT), together with 100 nmol of miR-1247 mimics or NC-mimics using Lipofectamine 2000 (Invitrogen). Forty-eight hours later, cells were measured using the Dual-Luciferase assay system (Promega, Madison, WI, USA) in accordance with the manufacturer’s instructions. Firefly luciferase activity was normalized to Renilla luciferase activity. Each treatment was performed for three times.
Quantitative data are presented as mean ± SD from at least three independent experiments. All statistical analyses were performed using the IBM SPSS Statistics software 21.0. Multiple group comparisons were performed using one-way analysis of variance (ANOVA). The differences between subgroups were analyzed by two-sample Student’s t-tests. A p value < 0.05 was considered significant.
MiR-1247 was under-expressed in NB tissues
MiR-1247 was associated with cellular proliferative inhibition in NB
MiR-1247 overexpression blocked cell cycle progression in NB cells
MiR-1247 overexpression promoted NB cell apoptosis
ZNF346 was a target gene of miR-1247 in NB
Downregulation of ZNF346 induced cell proliferation inhibition and apoptosis in NB cells
The miRNAs can recognize and directly bind to the 3′UTR sequence motifs of target genes in animals, and negatively regulate the production of the target gene’s protein product, thus affecting malignant cell behavior [24, 25]. The identification of functional roles and the probable mechanisms of miRNAs which abnormally expressed in cancer may supply valuable clues regarding miRNA-therapeutic strategies in oncology [26, 27]. Although miR-1247 is implicated in the progression of several tumor types, and the dysregulation of miR-1247 has also been detected in certain neoplastic tissues, the impacts of miR-1247 on NB and its potential targets have not yet been reported.
In this study, we have obtained the first data about the pathological function of miR-1247 in NB. Our results show that miR-1247 is less abundant in human NB tissues than that in adjacent tissues. Increasing levels of miR-1247 blocked the NB cells proliferation and colony formation and promoted apoptosis, whereas underexpression of miR-1247 had the opposite effect. Our results are similar with previous studies on pancreatic cancer , osteosarcoma , and NSCLC , which reveals that enhanced-expression of miR-1247 causes a decrease in cell viability. Furthermore, potential miR-1247 targets were identified by TargetScan, miRBase, and microRA.org databases. Dual-luciferase reporter assay showed that miR-1247 bound to recognition sites within the 3′UTR of ZNF346 and dramatically downregulated the ZNF346 at the post-translational level in NB cells. These results suggested that ZNF346 was a direct target of miR-1247 in NB. Moreover, the silencing of ZNF346 exerted qualitatively similar effects on cellular behavior as miR-1247 mimics, suggesting a role of ZNF346 in mediating miR-1247 inhibition of cell growth. Interestingly, previous studies reported that miR-1247 targeting neuroplilin 1 and neuroplilin 2 in pancreatic cancer, targeting MAP3K9 in osteosarcoma, and targeting STMN1 in NSCLC, thereby regulated tumor cells proliferation. These investigations revealed that miR1247 probably showed significantly different targets in various types of malignancies.
ZNF346 is a member of the C2H2-type zinc finger proteins that has a neuroprotective role in neurodegenerative disease models [23, 29, 30]. Mallick et al.  demonstrated that low ZNF346 expression attenuated neurons survival in vitro. However, ZNF346 expression is not altered in neurons which are primed to undergo apoptosis, implying a critical role for post-translational modification of ZNF346 in neuroprotection . In the present study, overexpression of miR-1247 and silencing of ZNF346 can both stimulate apoptosis. ZNF346 is a direct target of miR-1247 and its protein production was negatively regulated by miR-1247. We supposed that overexpression of miR-1247 in cultured NB cells led to their death though reduced ZNF346 protein levels via post-translational downregulation. Previous studies reported that neurons were also protected by ZNF346 from the following different paradigms, including interaction with SIRT, mut-Htt, and mut-Atx1 toxity. In the future, the concrete mechanism of miR-1247-induced apoptosis mediated by ZNF346 will be focused.
In summary, low miR-1247 expression in NB tissueswas observed compared with that in adjacent tissues. MiR-1247 suppresses the proliferation and colony formation and induces apoptosis by depressing its target protein ZNF346. This exploration expands our understanding about the regulation of ZNF346 at the post-translational level by miR-1247 in NB and suggests that the dysregulation of miR-1247 emerges a potential pathological mechanism in NB tumorigenesis. Moreover, our investigation may provide valuable clues for developing anti-cancer strategies.
ZX is major contributor and participated in the design of study; TW and YL performed this experiment and participated in the interpretation of data and revised the manuscript. All authors read and approved the final manuscript.
Competing of interest
The authors declare that they have no competing interests.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Consent for publication
The written informed consents had been signed by all patients in advance.
Ethics approval and consent to participate
The experiments were approved by ethics committee of the First People’s Hospital of Jingzhou.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Oldridge DA, et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature. 2015;528(7582):418–21.View ArticlePubMedPubMed CentralGoogle Scholar
- Pugh TJ, et al. The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013;45(3):279–84.View ArticlePubMedPubMed CentralGoogle Scholar
- Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203–16.View ArticlePubMedGoogle Scholar
- Kamijo T, Nakagawara A. Molecular and genetic bases of neuroblastoma. Int J Clin Oncol. 2012;17(3):190–5.View ArticlePubMedGoogle Scholar
- Sharp SE, Gelfand MJ, Shulkin BL. Pediatrics: diagnosis of neuroblastoma. Semin Nucl Med. 2011;41(5):345–53.View ArticlePubMedGoogle Scholar
- Lagos-Quintana M, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002;12(9):735–9.View ArticlePubMedGoogle Scholar
- Schmiedel JM, et al. Gene expression. MicroRNA control of protein expression noise. Science. 2015;348(6230):128–32.View ArticlePubMedGoogle Scholar
- Martinez-Sanchez A, Murphy CL. miR-1247 functions by targeting cartilage transcription factor SOX9. J Biol Chem. 2013;288(43):30802–14.View ArticlePubMedPubMed CentralGoogle Scholar
- Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation. 2010;121(8):1022–32.View ArticlePubMedPubMed CentralGoogle Scholar
- Pereira DM, et al. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013;18(5–6):282–9.View ArticlePubMedGoogle Scholar
- Cogswell JP, et al. Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008;14(1):27–41.View ArticlePubMedGoogle Scholar
- Agostini M, et al. Predictive response biomarkers in rectal cancer neoadjuvant treatment. Front Biosci (Schol Ed). 2014;6:110–9.View ArticleGoogle Scholar
- Agostini M, et al. An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. Oncotarget. 2015;6(32):32561–74.View ArticlePubMedPubMed CentralGoogle Scholar
- Xiang X, et al. miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14. Biochim Biophys Acta. 2015;1852(9):1743–54.View ArticlePubMedGoogle Scholar
- Yang H, et al. miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A. FEBS Lett. 2014;588(1):192–7.View ArticlePubMedGoogle Scholar
- Althoff K, et al. MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. Int J Cancer. 2013;133(5):1064–73.View ArticlePubMedGoogle Scholar
- Althoff K, et al. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int J Cancer. 2015;136(6):1308–20.View ArticlePubMedGoogle Scholar
- Liao W, et al. Downregulation of TrkA protein expression by miRNA92a promotes the proliferation and migration of human neuroblastoma cells. Mol Med Rep. 2014;10(2):778–84.View ArticlePubMedGoogle Scholar
- Shi S, et al. miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins. Curr Mol Med. 2014;14(3):316–27.View ArticlePubMedGoogle Scholar
- Scaravilli M, et al. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2. Prostate. 2015;75(8):798–805.View ArticlePubMedGoogle Scholar
- Zhang J, et al. Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1. OncoTargets Ther. 2016;9:7297–307.View ArticleGoogle Scholar
- Chu Y, et al. miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3. Oncol Rep. 2017;38(1):343–51.View ArticlePubMedGoogle Scholar
- Yang M, May WS, Ito T. JAZ requires the double-stranded RNA-binding zinc finger motifs for nuclear localization. J Biol Chem. 1999;274(39):27399–406.View ArticlePubMedGoogle Scholar
- Mallick S, D’Mello SR. JAZ (Znf346), a SIRT1-interacting protein, protects neurons by stimulating p21 (WAF/CIP1) protein expression. J Biol Chem. 2014;289(51):35409–20.View ArticlePubMedPubMed CentralGoogle Scholar
- Krek A, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495–500.View ArticlePubMedGoogle Scholar
- Konno Y, et al. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget. 2014;5(15):6049–62.View ArticlePubMedPubMed CentralGoogle Scholar
- D’Angelo E, et al. MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis. Curr Drug Targets. 2015;16(4):383–92.View ArticlePubMedGoogle Scholar
- Zhao F, et al. MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9. Int J Clin Exp Pathol. 2015;8(2):1451–8.PubMedPubMed CentralGoogle Scholar
- Tang BL, Chua CE. SIRT1 and neuronal diseases. Mol Aspects Med. 2008;29(3):187–200.View ArticlePubMedGoogle Scholar
- Jiang M, et al. Neuroprotective role of Sirt1 in mammalian models of Huntington’s disease through activation of multiple Sirt1 targets. Nat Med. 2011;18(1):153–8.View ArticlePubMedPubMed CentralGoogle Scholar